- Home
- ITRG vs RAPT Comparison
ITRG vs RAPT Comparison
Compare ITRG & RAPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITRG
- RAPT
- Stock Information
- Founded
- ITRG 1997
- RAPT 2015
- Country
- ITRG Canada
- RAPT United States
- Employees
- ITRG N/A
- RAPT N/A
- Industry
- ITRG Precious Metals
- RAPT Biotechnology: Pharmaceutical Preparations
- Sector
- ITRG Basic Materials
- RAPT Health Care
- Exchange
- ITRG Nasdaq
- RAPT Nasdaq
- Market Cap
- ITRG 452.9M
- RAPT 498.4M
- IPO Year
- ITRG N/A
- RAPT 2019
- Fundamental
- Price
- ITRG $3.24
- RAPT $28.02
- Analyst Decision
- ITRG Strong Buy
- RAPT Buy
- Analyst Count
- ITRG 2
- RAPT 7
- Target Price
- ITRG $3.25
- RAPT $35.14
- AVG Volume (30 Days)
- ITRG 2.2M
- RAPT 305.9K
- Earning Date
- ITRG 11-12-2025
- RAPT 11-11-2025
- Dividend Yield
- ITRG N/A
- RAPT N/A
- EPS Growth
- ITRG N/A
- RAPT N/A
- EPS
- ITRG 0.09
- RAPT N/A
- Revenue
- ITRG $148,447,000.00
- RAPT N/A
- Revenue This Year
- ITRG $871.24
- RAPT N/A
- Revenue Next Year
- ITRG N/A
- RAPT N/A
- P/E Ratio
- ITRG $35.35
- RAPT N/A
- Revenue Growth
- ITRG N/A
- RAPT N/A
- 52 Week Low
- ITRG $0.79
- RAPT $5.67
- 52 Week High
- ITRG $3.35
- RAPT $32.35
- Technical
- Relative Strength Index (RSI)
- ITRG 71.93
- RAPT 86.53
- Support Level
- ITRG $2.96
- RAPT $24.34
- Resistance Level
- ITRG $3.09
- RAPT $27.74
- Average True Range (ATR)
- ITRG 0.20
- RAPT 2.59
- MACD
- ITRG 0.00
- RAPT 0.69
- Stochastic Oscillator
- ITRG 92.01
- RAPT 83.95
About ITRG Integra Resources Corp.
Integra Resources Corp is a precious metals exploration and development company in the Great Basin of the Western USA. Integra is currently focused on advancing its two flagship oxide heap leach projects: the past-producing DeLamar Project located in southwestern Idaho and the Nevada North Project, comprised of the Wildcat and Mountain View deposits, located in northwestern Nevada. The company also holds a portfolio of prospective early-stage exploration projects in Idaho, Nevada, and Arizona.
About RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.